首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison of dosimetric variation between prostate IMRT and VMAT due to patient's weight loss: Patient and phantom study
Authors:James C.L. Chow  Runqing Jiang
Affiliation:aRadiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G 2M9, Canada;bDepartment of Radiation Oncology, University of Toronto, Toronto, ON, M5G 2M9, Canada;cMedical Physics Department, Grand River Regional Cancer Center, Kitchener, ON, N2G 1G3, Canada;dDepartment of Physics, University of Waterloo, Waterloo, ON, N2L 3G1, Canada
Abstract:

Aim

This study compared the dosimetric impact between prostate IMRT and VMAT due to patient''s weight loss.

Background

Dosimetric variation due to change of patient''s body contour is difficult to predict in prostate IMRT and VMAT, since a large number of small and irregular segmental fields is used in the delivery.

Materials and methods

Five patients with prostate volumes ranging from 32.0 to 86.5 cm3 and a heterogeneous pelvis phantom were used for prostate IMRT and VMAT plans using the same set of dose–volume constraints. Doses in IMRT and VMAT plans were recalculated with the patient''s and phantom''s body contour reduced by 0.5–2 cm to mimic size reduction. Dose coverage/criteria of the PTV and CTV and critical organs (rectum, bladder and femoral heads) were compared between IMRT and VMAT.

Results

In IMRT plans, increases of the D99% for the PTV and CTV were equal to 4.0 ± 0.1% per cm of reduced depth, which were higher than those in VMAT plans (2.7 ± 0.24% per cm). Moreover, increases of the D30% of the rectum and bladder per reduced depth in IMRT plans (4.0 ± 0.2% per cm and 3.5 ± 0.5% per cm) were higher than those of VMAT (2.2 ± 0.2% per cm and 2.0 ± 0.6% per cm). This was also true for the increase of the D5% for the right femoral head in a patient or phantom with size reduction due to weight loss.

Conclusions

VMAT would be preferred to IMRT in prostate radiotherapy, when a patient has potential to suffer from weight loss during the treatment.
Keywords:Prostate IMRT, Prostate VMAT, Patient''s weight loss, Treatment planning evaluation and dose–  volume points
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号